Comparison Chart Resverlogix Corp. OTC Markets
Stocks
RVXCF
CA76128M1086
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0649 USD | -0.66% |
|
-0.61% | -12.53% |
| 06-26 | Resverlogix Corp. - Shareholder/Analyst Call | |
| 05-16 | Resverlogix Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RESVERLOGIX CORP. | Bio Therapeutic Drugs | -0.66% | -0.61% | -12.53% | +134.30% | -91.00% | 21.81M |
-
|
-
|
-
|
- Stock Market
- Stocks
- RVX Stock
- RVXCF Stock
- Charts Resverlogix Corp.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
